Loading clinical trials...
Loading clinical trials...
The primary objective of this study is to evaluate the utility of the Banyan UCH-L1/GFAP Detection Assay as an aid in the evaluation of suspected traumatic brain injury (Glasgow Coma Scale score 9-15)...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Banyan Biomarkers, Inc
Collaborators
NCT03819608 · Mild Traumatic Brain Injury, Post Traumatic Stress Disorder
NCT06105892 · Convergence Insufficiency, Traumatic Brain Injury, and more
NCT07473505 · PTSD, Trauma-related Mental Health Symptoms, and more
NCT07246993 · Persistent Post Concussion Syndrome, Mild Traumatic Brain Injury
NCT04521881 · Traumatic Brain Injury
University of California San Diego
San Diego, California
Hartford Hospital
Hartford, Connecticut
University of Florida
Gainesville, Florida
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions